Angle Outlines Strategy As It Nears Major Regulatory Announcements

With approvals looming over the next few months, Angle spoke to Medtech Insight to probe deeper about its presentation at the 2021 Jefferies Healthcare Conference.

Angle’s core strategy is “all about getting the best sample,” Angle CEO Andrew Newland explained at the 2021 Jefferies Healthcare Conference on 17 November.

“Cancer is heterogenous; it’s dynamic,” he said, explaining that for each individual patient, their disease will progress at different rates,...